当前位置: 首页 > 期刊 > 《医学信息》 > 20204
编号:13514106
对比剂急性肾损伤的诊治(6)
http://www.100md.com 2020年1月29日 《医学信息》 20204
     [38]Gandhi S,Mosleh W,Abdel-Qadir H.Statins and contrast-induced acute kidney injury with coronary angiography[J].Am J Med 2014,127(10):987-1000.

    [39]Chanin JM,Yang DC,Haider MA,et al.Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention[J].J Invasive Cardiol,2015,27(11):490-496.

    [40]Anjum I,Akmal M,Hasnain N,et al.Statins role in preventing contrast-induced acute kidney injury:a scoping review[J].Hong Kong Med J,2019,25(3):216-221.

    [41]Arabmomeni M,Najafian J,Abdar Esfahani M,et al.Comparison between theophylline, N-acetylcysteine,and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy[J].ARYA Atheroscler,2015,11(1):43-49.

    [42]Dai B,Liu Y,Fu L,et al.Effect of theophylline on prevention of contrast-induced acute kidney injury:a meta-analysis of randomized controlled trials[J].Am J Kidney Dis,2012,60(3):360-370.

    [43]Cruz DN,Goh CY,Marenzi G,et al.Renal replacement therapies for prevention of radiocontrastinduced nephropathy:a systematic review[J].Am J Med,2012,125(1):66-78.e3.

    收稿日期:2019-10-17;修回日期:2019-11-22

    編辑/肖婷婷, http://www.100md.com(张军涛)
上一页1 2 3 4 5 6